First Manhattan’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.4M | Sell |
74,939
-7,226
| -9% | -$1.01M | 0.03% | 159 |
|
|
2025
Q4 | $10.1M | Sell |
82,165
-3,998
| -5% | -$486K | 0.03% | 166 |
|
|
2025
Q3 | $9.56M | Buy |
86,163
+26,296
| +44% | +$2.99M | 0.03% | 169 |
|
|
2025
Q2 | $6.64M | Buy |
59,867
+1,822
| +3% | +$194K | 0.02% | 197 |
|
|
2025
Q1 | $6.5M | Sell |
58,045
-39
| -0.1% | -$4.02K | 0.02% | 186 |
|
|
2024
Q4 | $5.37M | Sell |
58,084
-9,062
| -13% | -$816K | 0.02% | 204 |
|
|
2024
Q3 | $5.63M | Sell |
67,146
-4,052
| -6% | -$309K | 0.02% | 196 |
|
|
2024
Q2 | $4.88M | Sell |
71,198
-7,202
| -9% | -$481K | 0.02% | 206 |
|
|
2024
Q1 | $5.74M | Sell |
78,400
-5,942
| -7% | -$457K | 0.02% | 195 |
|
|
2023
Q4 | $6.83M | Sell |
84,342
-1,171
| -1% | -$91.1K | 0.02% | 182 |
|
|
2023
Q3 | $6.41M | Sell |
85,513
-3,266
| -4% | -$251K | 0.02% | 190 |
|
|
2023
Q2 | $6.84M | Sell |
88,779
-7,147
| -7% | -$570K | 0.03% | 179 |
|
|
2023
Q1 | $7.68M | Buy |
95,926
+507
| +0.5% | +$42K | 0.03% | 172 |
|
|
2022
Q4 | $7.87M | Sell |
95,419
-95,770
| -50% | -$7.58M | 0.03% | 175 |
|
|
2022
Q3 | $11.6M | Sell |
191,189
-16,959
| -8% | -$1.07M | 0.05% | 128 |
|
|
2022
Q2 | $12.5M | Sell |
208,148
-45,976
| -18% | -$2.85M | 0.05% | 133 |
|
|
2022
Q1 | $15.1M | Sell |
254,124
-42,859
| -14% | -$2.74M | 0.05% | 135 |
|
|
2021
Q4 | $21.6M | Sell |
296,983
-8,868
| -3% | -$611K | 0.07% | 112 |
|
|
2021
Q3 | $21.4M | Sell |
305,851
-296,426
| -49% | -$20.8M | 0.08% | 105 |
|
|
2021
Q2 | $41.5M | Sell |
602,277
-186,551
| -24% | -$12.5M | 0.15% | 72 |
|
|
2021
Q1 | $51M | Sell |
788,828
-250,251
| -24% | -$16.1M | 0.22% | 64 |
|
|
2020
Q4 | $60.5M | Sell |
1,039,079
-183,885
| -15% | -$11.1M | 0.29% | 53 |
|
|
2020
Q3 | $77.3M | Sell |
1,222,964
-116,736
| -9% | -$8.1M | 0.4% | 42 |
|
|
2020
Q2 | $103M | Buy |
1,339,700
+1,397
| +0.1% | +$107K | 0.6% | 31 |
|
|
2020
Q1 | $100M | Sell |
1,338,303
-345,648
| -21% | -$23.9M | 0.65% | 27 |
|
|
2019
Q4 | $109M | Sell |
1,683,951
-140,016
| -8% | -$9.12M | 0.55% | 38 |
|
|
2019
Q3 | $116M | Sell |
1,823,967
-162,196
| -8% | -$10.6M | 0.64% | 32 |
|
|
2019
Q2 | $134M | Sell |
1,986,163
-115,554
| -5% | -$7.6M | 0.74% | 28 |
|
|
2019
Q1 | $137M | Sell |
2,101,717
-83,082
| -4% | -$5.52M | 0.79% | 26 |
|
|
2018
Q4 | $137M | Sell |
2,184,799
-423,711
| -16% | -$29.6M | 0.85% | 22 |
|
|
2018
Q3 | $201M | Sell |
2,608,510
-107,318
| -4% | -$8.11M | 1.07% | 18 |
|
|
2018
Q2 | $192M | Sell |
2,715,828
-29,423
| -1% | -$2.08M | 1.11% | 15 |
|
|
2018
Q1 | $207M | Sell |
2,745,251
-31,887
| -1% | -$2.53M | 1.18% | 12 |
|
|
2017
Q4 | $199M | Sell |
2,777,138
-19,270
| -0.7% | -$1.46M | 1.09% | 15 |
|
|
2017
Q3 | $227M | Sell |
2,796,408
-84,500
| -3% | -$6.46M | 1.3% | 12 |
|
|
2017
Q2 | $204M | Sell |
2,880,908
-18,441
| -0.6% | -$1.23M | 1.19% | 13 |
|
|
2017
Q1 | $197M | Buy |
2,899,349
+215,359
| +8% | +$15.1M | 1.17% | 15 |
|
|
2016
Q4 | $192M | Buy |
2,683,990
+79,101
| +3% | +$5.88M | 1.17% | 17 |
|
|
2016
Q3 | $206M | Buy |
2,604,889
+573,597
| +28% | +$46.6M | 1.26% | 16 |
|
|
2016
Q2 | $169M | Buy |
2,031,292
+359,484
| +22% | +$31.9M | 1.04% | 18 |
|
|
2016
Q1 | $154M | Buy |
1,671,808
+127,631
| +8% | +$11.5M | 0.94% | 23 |
|
|
2015
Q4 | $156M | Buy |
1,544,177
+10,635
| +0.7% | +$1.11M | 0.96% | 24 |
|
|
2015
Q3 | $151M | Sell |
1,533,542
-19,203
| -1% | -$2.13M | 0.97% | 22 |
|
|
2015
Q2 | $182M | Sell |
1,552,745
-15,968
| -1% | -$1.74M | 1.07% | 23 |
|
|
2015
Q1 | $154M | Buy |
1,568,713
+6,499
| +0.4% | +$660K | 0.89% | 24 |
|
|
2014
Q4 | $147M | Buy |
1,562,214
+25,665
| +2% | +$2.65M | 0.83% | 25 |
|
|
2014
Q3 | $164M | Buy |
1,536,549
+28,533
| +2% | +$2.79M | 0.95% | 21 |
|
|
2014
Q2 | $125M | Buy |
1,508,016
+450,911
| +43% | +$35.1M | 0.79% | 28 |
|
|
2014
Q1 | $74.9M | Sell |
1,057,105
-6,626
| -0.6% | -$520K | 0.49% | 47 |
|
|
2013
Q4 | $79.9M | Sell |
1,063,731
-14,187
| -1% | -$988K | 0.53% | 44 |
|
|
2013
Q3 | $67.8M | Sell |
1,077,918
-26,505
| -2% | -$1.58M | 0.47% | 45 |
|
|
2013
Q2 | $68.5M | Buy |
+1,104,423
| New | +$57.6M | 0.47% | 43 |
|
Other funds holding GILD
VCM
VPM
First Manhattan's GILD Position: Q1 2026 in Review
First Manhattan reduced its Gilead Sciences (GILD) stake by 8.8% in Q1 2026, selling an estimated $1.01M and leaving 74,939 shares worth $10.4M. The position accounts for 0.03% of the portfolio, ranked #159.
First Manhattan first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $227M in Q3 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- First Manhattan held 74,939 shares of Gilead Sciences worth $10.4M as of Q1 2026.
- First Manhattan sold 7,226 Gilead Sciences shares in Q1 2026, an estimated $1.01M.
- Gilead Sciences made up 0.03% of First Manhattan's portfolio in Q1 2026, its #159 holding.
- First Manhattan first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- First Manhattan's Gilead Sciences position peaked at $227M in Q3 2017.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.